Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 7
Original Research
Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 22,680 | Dovepress* | 18,429+ | 1,963 | 20,392 | |
| PubMed Central* | 4,251 | 665 | 4,916 | ||
| Totals | 22,680 | 2,628 | 25,308 | ||
|
*Since 12 May 2015 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 6 | 0 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar